 |
|
|
| |
"Treatment of Genotype 3 Cirrhotic patients with 12
weeks Sofosbuvir/Velpatasvir with or without ribavirin:
Real life experience from Italy"
|
| |
| |
Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
Luisa Pasulo on behalf Italian Real life HCV cirrhotic G3 Study Group
(Navigatore Lombardy and Veneto, Piemonte, Tuscany, Sicily)
E-mail: lpasulo@asst-pg23.it
|
| |
|
|
|
|
|
